Skip to content
Intravacc
  • About Us
    • About Us
    • Management and Industry Advisory Board
    • Track Record
    • News
    • Events
    • Careers
    • Partners
  • Development Services
    • Platforms
    • Tech Transfer
    • Process Development
    • Analytical Development
    • cGMP Manufacturing
    • Quality & Regulation
  • Analytical Services
    • Identity & Content
    • Purity
    • Structure
    • Formulation
    • Preclinical
  • Knowledge Center
    • Research
    • Scientific Publications
    • Downloads
    • Newsletter
  • Contact Us
  • Toggle website search
Menu Close

E.co-Vacc technology

  1. Home>
  2. Development Services>
  3. Platforms>
  4. E.co-Vacc technology

    Contact

    Utrecht Science Park Bilthoven
    Antonie van Leeuwenhoeklaan 9
    3721 MA Bilthoven

    PO Box 450
    3720 AL Bilthoven
    The Netherlands

    Contact

    Phone: +31 30 792 03 00
    Email: info@intravacc.nl

    Business Development: BD@intravacc.nl

    Linkedin Youtube

    Information

    Standard Terms & Conditions

    Services & Procurement

    Privacy & Disclaimer

    Our Certifications

    Contact

    About Us

    Knowledge Center

    Services: development / analytical

    Contact Us

    Copyright 2026 - Intravacc - Part of Utrecht Science Park Bilthoven
    Search this website Type then hit enter to search
    Close Menu

    Cell Banks MCB / WCB
    Virus Seeds MVS / WVS
    Pre-clinical + Phase I – III + comm.
    Drug Substance Manufacturing
    Drug Product Manufacturing
    Regulatory Support
    Technical Transfer
    Stability Tests

    Immunogenicity studies
    Adjuvant evaluation studies
    Dose ranging/finding studies
    Toxicology studies

    Formulation feasibility
    Characterization and assay selection
    Formulation optimization
    Development stability studies
    Device compatibility studies
    In-use stability study
    Lyophilization

    Immunological assays
    Biochemical assays
    Biophysical assays
    Cell-based assays
    Analytical chemical assays

    Clarification
    Chromatography
    Tangential Flow Filtration
    Dead-end-filtration
    Final filtration (sterile 0.2μm)
    Lyophilization

    Mammalian
    Microbial fermentation
    Adherent
    Suspension
    Up to 200L

    Viral vaccine design
    Bacterial vaccine design
    Therapeutic vaccine design
    Antigen selection
    GMP readiness

    Bacterial vaccines
    Viral vaccines
    Conjugate vaccines
    E.coli expressed protein vaccines

    Infectious Diseases
    Oncology
    Immunology
    Auto-immune diseases
    Neurodegenerative CNS
    AntiMicrobial Resistance
    Respiratory
    Parasitic and fungal

    Discovery
    Development
    Pre-clinical
    GMP Manufacturing
    Phase I/II
    Large-scale manufacturing
    Phase III/IV
    Registration and distribution